Nutrien (NYSE:NTR) was upgraded by equities research analysts at Scotiabank from an “outperform” rating to a “focus list” rating in a research report issued on Monday, February 12th. The brokerage presently has a $60.00 price target on the stock. Scotiabank’s price objective indicates a potential upside of 22.03% from the stock’s previous close.
A number of other research firms also recently weighed in on NTR. Royal Bank of Canada assumed coverage on Nutrien in a research report on Monday, January 8th. They set an “outperform” rating and a $60.00 target price for the company. Bank of America initiated coverage on Nutrien in a research report on Friday, January 5th. They set an “underperform” rating and a $50.00 price objective for the company. Macquarie initiated coverage on Nutrien in a research report on Friday, January 5th. They set an “outperform” rating and a $59.00 price objective for the company. Credit Suisse Group initiated coverage on Nutrien in a research report on Friday, January 5th. They set a “neutral” rating and a $53.00 price objective for the company. Finally, Raymond James Financial initiated coverage on Nutrien in a research report on Friday, January 5th. They set a “market perform” rating and a $60.00 price objective for the company. One analyst has rated the stock with a sell rating, five have assigned a hold rating, ten have given a buy rating and two have assigned a strong buy rating to the company. Nutrien has an average rating of “Buy” and a consensus price target of $58.50.
Nutrien (NYSE NTR) traded up $1.59 on Monday, reaching $49.17. The company had a trading volume of 762,234 shares, compared to its average volume of 1,996,264. The company has a market cap of $15,821.97, a P/E ratio of 34.60, a PEG ratio of 1.90 and a beta of 0.43. The company has a debt-to-equity ratio of 0.45, a current ratio of 2.07 and a quick ratio of 1.58. Nutrien has a twelve month low of $40.41 and a twelve month high of $56.18.
A hedge fund recently bought a new stake in Nutrien stock. Verity Asset Management Inc. purchased a new position in Nutrien Ltd. (NYSE:NTR) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 11,354 shares of the company’s stock, valued at approximately $594,000.
COPYRIGHT VIOLATION NOTICE: “Nutrien (NYSE:NTR) Raised to Focus List at Scotiabank” was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this article on another website, it was illegally copied and republished in violation of international trademark and copyright laws. The original version of this article can be read at https://www.dispatchtribunal.com/2018/02/23/scotiabank-upgrades-nutrien-ntr-to-focus-list.html.
Nutrien Ltd. produces and distributes potash, nitrogen, and phosphate products for agricultural, industrial, and feed customers worldwide. It offers potash crop feed, fertilizer, industrial, metal finishing, and purified acid products, as well as blends. The company is also involved in the retail operations that serve growers in seven countries across three continents.
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.